Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Michiel S. Van Der Heijden | Researchclopedia

Back to researchers

Michiel S. Van Der Heijden

Dutch Cancer Society

4

Works

0

Citations

0

h-index

0

i10-index

Research Topics

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment

Affiliations

Dutch Cancer Society2026–2026

The Netherlands Cancer Institute2026–2026

Top Works

Induction ipilimumab plus nivolumab followed by consolidating chemoradiotherapy as bladder-sparing treatment in stage II/III urothelial carcinoma of the bladder: The phase 2 Indi-Blade trial.

Jan-Jaap Jelmer Mellema,Chantal Stockem,et al.

20260 citations

Prostate Cancer Treatment and Research

Cancer Genomics and Diagnostics

KEYMAKER-U04 substudy 04B: First-line (1L) enfortumab vedotin (EV) plus pembrolizumab (pembro)-based immune checkpoint inhibitor (ICI) combinations for advanced urothelial cancer (UC).

Michiel S. Van Der Heijden,Michal Sarfaty,et al.

20260 citations

Characterization of patients (pts) responding to enfortumab vedotin plus pembrolizumab (EV+P): Exploratory analysis from the phase 3 EV-302 trial of EV+P vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).

Shilpa Gupta,Jens Bedke,et al.

20260 citations

Urinary tumor DNA (utDNA) and circulating tumor DNA (ctDNA) in patients (pts) with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA.

Michiel S. Van Der Heijden,Matthew D. Galsky,et al.

20260 citations